Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07179848

Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders

Phase I Clinical Trial of a New Non-invasive Deep Brain Stimulation Technique

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to validate if temporal interference brain stimulation (TIBS) is safe in healthy volunteers aged 20 to 65. The main questions it aims to answer are: * Is it safe to apply TIBS intervention to the left hippocampus in healthy participants? * Is it safe to apply TIBS intervention to the left insula in healthy participants? * Is it safe to apply TIBS intervention to the left anterior cingulate cortex in healthy participants? * Is it safe to apply TIBS intervention to the right inferior frontal cortex in healthy participants? Participants will: * Be Randomly allocated to either sham-first group or treat first-group, stratified by stimulated brain region, following a crossover-controlled experimental design * Complete baseline cognitive evaluations and mental status assessments, and undergo a baseline MRI scan on the same day * Receive stimulation for 5 consecutive days, followed by a 2-days washout period, then complete the remaining 5 days of stimulation. * Complete post-intervention cognitive evaluations and mental status assessments, and undergo a post-intervention MRI scan on the same day

Conditions

Interventions

TypeNameDescription
DEVICETemporal Interference Stimulation - Treatment firstReceive treatment stimulation for 5 consecutive days, followed by a 2-days washout period, then complete the remaining 5 days of sham stimulation
DEVICETemporal Interference Stimulation - Sham firstReceive sham stimulation for 5 consecutive days, followed by a 2-days washout period, then undergo 5 days of treatment stimulation

Timeline

Start date
2025-02-26
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2025-09-18
Last updated
2026-02-09

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07179848. Inclusion in this directory is not an endorsement.